The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

For many years, health experts have been concerned about "food deserts," places where residents lack good nutritional options ...

This segment is sponsored by Eli Lilly and Company.Social media is flooded with advertisments for popular obestiy medications ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

Obesity medications, once facing shortages, are now widely available. So how do consumers not get scammed into purchasing ...

Racial disparities in childhood obesity have risen due to social determinants, food insecurity, and systemic barriers, ...

SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

More or Less is produced in partnership with the Open University. Presenter: Tim Harford Reporter: Lizzy McNeill Producer: ...

SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier CB ...

For years, people living with obesity have been given the same basic advice: eat less, move more. But while this mantra may ...